RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE
批准号:
2910761
负责人:
JANG-HO J CHA
金额:
$24.14万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-12 至 2003-07-31
关键词:
Huntington's disease disease /disorder model dopamine receptor gene mutation genetic transcription genetically modified animals glutamate receptor human tissue immunocytochemistry inclusion body laboratory mouse neurogenetics nucleic acid repetitive sequence postmortem purinergic receptor receptor expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) Recently Huntington's
disease (HD) and other triplet repeat disorders were found to be caused by
expansions in the length of CAG codon repeat stretches in the mutated genes and
mice transgenic for these mutations were created. The deleterious, biochemical
consequences of this type of mutation remain unknown. Any clues to the
biochemical effects of the mutation may, therefore, be vital clues to the toxic
consequences of the mutation. We have found striking changes in dopamine D1 and
D2, adenosine A2a and metabotropic glutamate type 2 receptor mRNA expression in
three strains of mice transgenic for exon 1 of the HD gene with increased
polyglutamines. The observed changes in receptor mRNA suggest that the
truncated HD protein alters gene transcription. Few other biochemical changes
have been found in HD transgenic mice. As such, it is one of the very few clues
we can use to determine the pathologic mechanism of the disease. While receptor
changes may themselves not cause disease, our data strongly suggest that
receptor changes reflect a crucial, deleterious process which may include
dysregulation of gene expression. Further, the magnitude of the change we have
found (up to 90% decrease in presymptomatic mice) provides a strong readout
that can be used in mechanistic and therapeutic studies. We will determine the
generalizability and validity of these changes by measuring the levels of mRNA
and protein expression for these receptors and control receptors in identified
neuronal types of cortex, striatum, hippocampus and cerebellum in HD transgenic
and littermate control mice as well as post-mortem presymptomatic HD and
control human brains using techniques we have developed over the last 15 years;
double label isotopic and nonisotopic in situ hybridization, immunoblotting,
ligand binding assays and immuno-cytochemistry. We also will determine the
relationship of the changes to the development of the neuronal intranuclear
inclusions. (NII) that have been seen in both these mice and in human HD,
whether they occur in cultured cells transfected with the mutant HD gene and
the degree to which receptor changes correlate with CAG repeat number in human,
mouse and cultured cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2009 CAG Triplet Repeat Disorders Gordon Research Conference
-
批准号:7671898
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2009
-
负责人:JANG-HO J CHA
-
依托单位:
Chromatin remodeling in transgenic mouse models of HD
-
批准号:6741051
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2003
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE
-
批准号:6394035
-
项目类别:
-
资助金额:$42.38万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE
-
批准号:6187964
-
项目类别:
-
资助金额:$30.73万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
-
批准号:7064211
-
项目类别:
-
资助金额:$35.57万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
-
批准号:7220036
-
项目类别:
-
资助金额:$34.53万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE
-
批准号:6529239
-
项目类别:
-
资助金额:$44.4万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
-
批准号:6826505
-
项目类别:
-
资助金额:$36.32万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
-
批准号:6922043
-
项目类别:
-
资助金额:$36.42万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
-
批准号:7414519
-
项目类别:
-
资助金额:$34.53万
-
财政年份:1999
-
负责人:JANG-HO J CHA
-
依托单位:
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
-
批准号:6297987
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:JANG-HO J CHA
-
依托单位:
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
-
批准号:6297903
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:JANG-HO J CHA
-
依托单位:
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
-
批准号:6119041
-
项目类别:
-
资助金额:$0.08万
-
财政年份:1998
-
负责人:JANG-HO J CHA
-
依托单位:
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
-
批准号:6220194
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:JANG-HO J CHA
-
依托单位:
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
-
批准号:6280062
-
项目类别:
-
资助金额:$2.74万
-
财政年份:1997
-
负责人:JANG-HO J CHA
-
依托单位:
METABOTROPIC RECEPTORS AND EXCITOTOXICITY
-
批准号:2260120
-
项目类别:
-
资助金额:$7.89万
-
财政年份:1996
-
负责人:JANG-HO J CHA
-
依托单位:
METABOTROPIC RECEPTORS AND EXCITOTOXICITY
-
批准号:2771875
-
项目类别:
-
资助金额:$11.08万
-
财政年份:1996
-
负责人:JANG-HO J CHA
-
依托单位:
METABOTROPIC RECEPTORS AND EXCITOTOXICITY
-
批准号:2891419
-
项目类别:
-
资助金额:$11.08万
-
财政年份:1996
-
负责人:JANG-HO J CHA
-
依托单位:
METABOTROPIC RECEPTORS AND EXCITOTOXICITY
-
批准号:6186971
-
项目类别:
-
资助金额:$11.38万
-
财政年份:1996
-
负责人:JANG-HO J CHA
-
依托单位:
METABOTROPIC RECEPTORS AND EXCITOTOXICITY
-
批准号:2519889
-
项目类别:
-
资助金额:$8.97万
-
财政年份:1996
-
负责人:JANG-HO J CHA
-
依托单位: